Fairfax Competitors

Summary

FRFHFDelisted Stock

USD 766.50 2.38 0.31%

Fairfax Financial competes with RLI Corp, Chubb, Progressive Corp, White Mountains, and W R; as well as few others. The company classifies itself under Insurance sector and is part of Financials industry. Analyzing Fairfax Financial competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Fairfax Financial to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Fairfax Financial competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
766.50	766.50	766.50

Details

Intrinsic

Valuation

Low	Real	High
634.47	634.47	843.15

Details

Naive

Forecast

Low	Next	High
789.04	789.04	789.04

Details

Bollinger

Band Projection (param)

Lower	Middle Band	Upper
731.64	749.71	767.79

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Fairfax Financial. Your research has to be compared to or analyzed against Fairfax Financial's peers to derive any actionable benefits. When done correctly, Fairfax Financial's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Fairfax Financial.

Fairfax Financial Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Fairfax Financial and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Fairfax and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Fairfax Financial does not affect the price movement of the other competitor.

	RLI	CB	PGR	WTM	WRB-PE	WRB	KNSL	UFCS	SKWD	MKL
RLI		-0.11	0.7	0.92	-0.33	0.86	0.62	0.92	0.95	0.94	RLI
CB	-0.11		0.07	-0.09	0.24	0.1	0.25	-0.11	-0.09	-0.05	CB
PGR	0.7	0.07		0.55	0.04	0.68	0.77	0.81	0.55	0.8	PGR
WTM	0.92	-0.09	0.55		-0.48	0.92	0.64	0.84	0.94	0.87	WTM
WRB-PE	-0.33	0.24	0.04	-0.48		-0.39	-0.25	-0.27	-0.35	-0.28	WRB-PE
WRB	0.86	0.1	0.68	0.92	-0.39		0.74	0.85	0.85	0.88	WRB
KNSL	0.62	0.25	0.77	0.64	-0.25	0.74		0.68	0.54	0.72	KNSL
UFCS	0.92	-0.11	0.81	0.84	-0.27	0.85	0.68		0.85	0.97	UFCS
SKWD	0.95	-0.09	0.55	0.94	-0.35	0.85	0.54	0.85		0.88	SKWD
MKL	0.94	-0.05	0.8	0.87	-0.28	0.88	0.72	0.97	0.88		MKL
	RLI	CB	PGR	WTM	WRB-PE	WRB	KNSL	UFCS	SKWD	MKL

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

High positive correlations

MKL	+ 0.97	UFCS
SKWD	+ 0.95	RLI
MKL	+ 0.94	RLI
SKWD	+ 0.94	WTM
WTM	+ 0.92	RLI
UFCS	+ 0.92	RLI

High negative correlations

WRB-PE	- 0.48	WTM
WRB	- 0.39	WRB-PE
SKWD	- 0.35	WRB-PE
WRB-PE	- 0.33	RLI
MKL	- 0.28	WRB-PE
UFCS	- 0.27	WRB-PE

Risk-Adjusted Indicators

There is a big difference between Fairfax Pink Sheet performing well and Fairfax Financial Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Fairfax Financial's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RLI	0.87	0.10	0.08	0.20	1.15	(0.97)	1.76	(1.82)	7.00
CB	0.83	(0.04)	(0.07)	0.02	1.26	(0.81)	1.49	(1.78)	6.25
PGR	0.90	(0.04)	(0.04)	0.06	1.03	(1.03)	2.45	(1.72)	6.25
WTM	0.97	0.00	0.01	0.10	1.00	(1.11)	2.38	(1.73)	7.13
WRB-PE	0.45	0.02	(0.13)	0.60	0.48	(0.47)	0.81	(0.88)	2.09
WRB	1.07	0.01	0.00	0.11	1.42	(1.07)	2.03	(2.36)	7.07
KNSL	1.40	(0.13)	(0.03)	0.02	2.04	(1.45)	2.57	(2.97)	9.90
UFCS	1.90	0.33	0.34	0.20	1.11	(2.36)	4.67	(2.44)	28.11
SKWD	1.42	0.30	0.16	0.34	1.62	(1.59)	3.41	(2.38)	10.47
MKL	0.88	0.01	0.02	0.11	1.03	(0.89)	1.84	(1.80)	7.55

Unable to evaluate fundamental data of [RLI, CB, PGR, WTM, WRB-PE, WRB, KNSL, UFCS, SKWD, MKL, NODK, DGICA, DGICB, THG, HMN, SIGI, ARGO-PA, GBLI, KMPR] at this time. Please try again later

All Fundamental Data

Fairfax Financial Competitive Analysis

The better you understand Fairfax Financial competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Fairfax Financial's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Fairfax Financial's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	FRFHF	RLI	CB	PGR	WTM	WRB-PE	WRB	KNSL	UFCS	SKWD
	0.31 766.50 Fairfax	0.04 173.48 RLI	1.26 286.25 Chubb	0.54 262.61 Progressive	1.15 1,984 White	0.40 25.11 WRB-PE	0.20 63.52 WRB	0.14 499.95 Kinsale	0.58 30.66 United	0.35 54.16 Skyward
Market Volatility (90 Days Market Risk)	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady	Not too volatile	Very steady
Market Performance (90 Days Performance)	Very Weak	Good	Very Weak	Modest	Good	Weak	OK	Modest	Good	Solid
Odds of Financial Distress (Probability Of Bankruptcy)	Dangerous	Low	Very Low	Very Low	Low	Low	Low	Low	Low	Very Low
Current Valuation (Equity Enterprise Value)	Over Valued	Fairly Valued	Over Valued	Over Valued	Over Valued	Fairly Valued	Under Valued	Over Valued	Over Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Buy	Buy	Buy	Strong Sell	Not Available	Buy	Buy	Hold	Strong Buy
Trade Advice (90 Days Macroaxis Advice)	Not Rated	Strong Buy	Strong Hold	Strong Hold	Strong Hold	Sell	Strong Hold	Strong Hold	Strong Buy	Buy
Current Ratio	1.8	1.43	0.37	0.41	1.95	N/A	0.42	0.25	0.32	N/A
Net Asset	86.65 B	5.18 B	230.68 B	88.69 B	8.39 B	32.09 B	32.91 B	3.77 B	3.14 B	2.95 B
Profit Margin	0.004	0.24	0.18	0.11	0.24	N/A	0.12	0.27	0.0415	0.12
EBITDA	984.1 M	(5.54 M)	91 M	5.47 B	610.3 M	1.56 B	1.86 B	397.59 M	(25.95 M)	(1.68 M)
Operating Margin	0.0337	0.25	0.2	0.15	0.42	N/A	0.16	0.35	0.085	0.16
Current Valuation	15.77 B	7.99 B	135.44 B	161.43 B	5.43 B	N/A	25.56 B	11.7 B	701.19 M	2.18 B
Price To Book	1.02	4.55	1.78	5.7	1.12	N/A	2.88	8.1	0.99	2.72
Retained Earnings	3.1 B	1.61 B	54.81 B	18.8 B	3.69 B	N/A	11.04 B	828.25 M	574.69 M	(21.71 M)
Five Year Return	2.3	1.07	1.99	2.44	0.1	N/A	0.68	0.31	3.01	N/A
Current Asset	N/A	N/A	N/A	N/A	1.23 B	N/A	N/A	129.64 M	N/A	N/A
Beta	0.96	0.38	0.68	0.37	0.43	N/A	0.62	1.09	0.38	N/A
Number Of Employees	15.89 K	1.1 K	40 K	61.43 K	782	N/A	8.33 K	561	852	515
Shares Outstanding	23.45 M	45.82 M	403.1 M	585.81 M	2.57 M	N/A	381.07 M	23.29 M	25.34 M	40.1 M
Cash Flow From Operations	6.64 B	464.26 M	12.63 B	10.64 B	404.1 M	2.18 B	2.93 B	859.84 M	171.74 M	338.19 M
Annual Yield	0.0154	0.0067	0.0126	0.0015	5.0E-4	0.0613	0.0048	0.0012	0.0208	N/A
Total Debt	7.75 B	100 M	14.49 B	6.89 B	564.6 M	1.17 M	2.84 B	183.85 M	50 M	128.69 M
Return On Equity	0.0088	0.28	0.16	0.36	0.16	N/A	0.21	0.35	0.0701	0.2
Z Score	1.2	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return On Asset	0.0061	0.0597	0.0292	0.069	0.0692	N/A	0.036	0.0789	0.0128	0.0353
Number Of Shares Shorted	100.28 K	476.2 K	3.56 M	4.28 M	39.41 K	N/A	4.52 M	569.74 K	423.79 K	861.32 K
Book Value Per Share	569.97	38.17	163.16	46.36	1820.39	N/A	22.11	61.62	31.01	19.89
Current Liabilities	N/A	N/A	N/A	N/A	2.23 B	N/A	N/A	49.34 M	N/A	N/A
Total Asset	86.65 B	5.18 B	230.68 B	88.69 B	8.39 B	32.09 B	32.91 B	3.77 B	3.14 B	2.95 B
Debt To Equity	0.45	0.15	0.43	0.43	0.19	N/A	0.48	0.067	0.064	N/A
Short Ratio	1.8	2.9	2.33	1.9	3.0	N/A	2.25	7.89	4.16	2.55
Target Price	624.39	178.4	298.91	276.81	360.0	N/A	63.86	465.88	26.0	51.44
Last Dividend Paid	10.0	1.12	3.54	1.15	1.0	0.56	0.31	0.59	0.64	N/A
Shares Owned By Institutions	33.13	81.29	84.31	87.1	90.27	N/A	69.29	87.97	65.77	98.86
Market Capitalization	16.31 B	7.95 B	115.39 B	153.84 B	5.1 B	2.95 B	24.21 B	11.63 B	776.99 M	2.17 B
Price To Earning	31.43	20.64	15.3	93.06	6.14	5.82	16.21	60.48	11.71	N/A
Price To Earnings To Growth	14.13	3.82	3.62	1.05	9.93	N/A	3.33	1.77	2.9	0.9
Price To Sales	0.58	4.5	2.11	2.14	1.86	N/A	1.83	7.62	0.64	1.99
Net Income	3.4 B	304.61 M	9.03 B	3.9 B	509.2 M	1.53 B	1.38 B	308.09 M	(29.7 M)	85.98 M
Earnings Per Share	18.07	9.09	24.38	13.76	252.36	N/A	3.9	17.52	1.95	3.27
Shares Owned By Insiders	3.3	4.39	7.31	0.28	3.11	N/A	24.26	5.32	18.23	12.81
Revenue	25.8 B	1.52 B	50 B	62.08 B	2.17 B	9.46 B	12.14 B	1.22 B	1.1 B	895.4 M
Working Capital	N/A	N/A	N/A	N/A	(1000 M)	N/A	N/A	80.3 M	N/A	N/A
Cash And Equivalents	7.7 B	22.82 M	6.66 B	4.59 B	623 M	N/A	1.45 B	131.66 M	92.21 M	N/A
Cash Per Share	328.63	15.94	16.05	7.84	217.18	N/A	8.65	5.75	3.66	N/A
Gross Profit	12.68 B	832.6 M	10.63 B	1.69 B	370.9 M	N/A	4.81 B	155.87 M	15.27 M	174.21 M
Day Typical Price	769.62	173.5	288.15	263.68	1981.32	25.11	63.48	500.13	30.55	53.94
Accumulation Distribution	0.0155	0.0085	0.0232	0.0158	0.0048	0.0075	0.0128	0.0187	0.0272	0.0164
Market Facilitation Index	12.08	1.48	6.8	4.22	9.48	0.19	0.82	9.42	0.84	0.89
Daily Balance Of Power	(0.20)	(0.05)	(0.54)	(0.34)	(2.44)	(0.53)	(0.16)	0.0722	(0.21)	0.2135
Period Momentum Indicator	(2.38)	(0.07)	(3.66)	(1.43)	(23.16)	(0.10)	(0.13)	0.68	(0.18)	0.19
Rate Of Daily Change	1.0	1.0	0.99	0.99	0.99	1.0	1.0	1.0	0.99	1.0
Day Median Price	771.18	173.51	289.1	264.21	1979.74	25.12	63.46	500.22	30.49	53.83
Price Action Indicator	(5.87)	(0.07)	(4.68)	(2.31)	(6.84)	(0.06)	(0.01)	0.07	0.08	0.43
Relative Strength Index	48.45	71.18	47.36	52.4	60.81	39.1	54.83	56.29	78.76	74.38
Coefficient Of Variation	838.98	590.93	5116.34	1798.33	1183.6	1358.22	1261.77	4200.59	532.77	448.07
Mean Deviation	1.08	0.8726	0.8343	0.9024	0.9709	0.4468	1.07	1.4	1.9	1.42
Jensen Alpha	0.103	0.1029	(0.04)	(0.04)	(0)	0.0248	0.0057	(0.13)	0.3282	0.3031
Total Risk Alpha	(0.03)	0.0344	(0.14)	(0.11)	(0.08)	(0.04)	(0.09)	(0.23)	0.1796	0.1658
Sortino Ratio	0.0387	0.08	(0.07)	(0.04)	0.0068	(0.13)	(0.0005)	(0.03)	0.3432	0.1597
Downside Variance	1.74	1.85	1.68	1.24	1.31	0.3164	2.37	4.35	2.73	4.37
Standard Deviation	1.38	1.31	1.14	1.25	1.43	0.5427	1.42	1.95	3.63	2.0
Kurtosis	(0.07)	5.66	3.59	2.27	4.71	(0.73)	1.28	2.9	27.25	2.17
Potential Upside	2.52	1.76	1.49	2.45	2.38	0.8081	2.03	2.57	4.67	3.41
Treynor Ratio	0.3107	0.2007	0.0222	0.0634	0.0999	0.598	0.1094	0.023	0.2023	0.3369
Maximum Drawdown	6.33	7.0	6.25	6.25	7.13	2.09	7.07	9.9	28.11	10.47
Variance	1.9	1.72	1.29	1.57	2.05	0.2945	2.02	3.8	13.16	4.02
Market Risk Adjusted Performance	0.3207	0.2107	0.0322	0.0734	0.1099	0.608	0.1194	0.033	0.2123	0.3469
Risk Adjusted Performance	0.0954	0.1333	0.0182	0.0463	0.0691	0.0521	0.0651	0.0242	0.1511	0.1765
Skewness	(0.07)	(0.43)	(0.94)	0.4059	1.27	(0.17)	(0.28)	(0.66)	4.46	(0.29)
Semi Deviation	1.21	1.15	1.26	1.03	1.0	0.4768	1.42	2.04	1.11	1.62
Information Ratio	0.037	0.0829	(0.08)	(0.03)	0.0054	(0.14)	(0.0005)	(0.03)	0.1565	0.1666
Value At Risk	(2.32)	(1.82)	(1.78)	(1.72)	(1.73)	(0.88)	(2.36)	(2.97)	(2.44)	(2.38)
Expected Short fall	(1.21)	(0.97)	(0.81)	(1.03)	(1.11)	(0.47)	(1.07)	(1.45)	(2.36)	(1.59)
Downside Deviation	1.32	1.36	1.29	1.11	1.14	0.5625	1.54	2.09	1.65	2.09
Semi Variance	1.46	1.33	1.6	1.07	1.01	0.2274	2.01	4.17	1.24	2.61

Fairfax Financial Competition Performance Charts

Five steps to successful analysis of Fairfax Financial Competition

Fairfax Financial's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Fairfax Financial in relation to its competition. Fairfax Financial's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Fairfax Financial in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Fairfax Financial's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Fairfax Financial, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Fairfax Financial position

In addition to having Fairfax Financial in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Healthcare Thematic Idea Now

Healthcare

Companies that provide healthcare goods and services including hospitals, health maintenance organizations, HMOs, or medical aid manufacturers. The Healthcare theme has 20 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.

View All Next

Launch

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Consideration for investing in Fairfax Pink Sheet

If you are still planning to invest in Fairfax Financial check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Fairfax Financial's history and understand the potential risks before investing.

	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Commodity Directory Find actively traded commodities issued by global exchanges
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Fairfax Competitors

Specify up to 10 symbols:

Fairfax Financial Competition Correlation Matrix

Risk-Adjusted Indicators

Fairfax Financial Competitive Analysis

Fairfax Financial Competition Performance Charts

Five steps to successful analysis of Fairfax Financial Competition

Complement your Fairfax Financial position

Did You Try This Idea?

Run Healthcare Thematic Idea Now

Healthcare

Other Consideration for investing in Fairfax Pink Sheet

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY